0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
China Acute Migraine Drugs Market Report & Forecast 2021-2027
Published Date: August 2021
|
Report Code: QYRE-Auto-15T1655
Home | Market Reports | Health | Health Conditions | Pain Management
China Acute Migraine Drugs Market Report Forecast 2021 2027

China Acute Migraine Drugs Market Report & Forecast 2021-2027

Code: QYRE-Auto-15T1655
Report
August 2021
92 Pages
QYResearch
Region: Global, Japan, India, North America, Middle East, Europe, Germany, France, South Korea, Australia, Philippines, Malaysia, Thailand, Indonesia, Turkey, Saudi Arabia, Taiwan, Italy, China,
Description
Table of Content
Tables & Figures
China Acute Migraine Drugs Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K Unit)
China Acute Migraine Drugs Market Segment Percentages, By Type, 2020 (%)
Triptans
NSAIDs
Others
China Acute Migraine Drugs Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (K Unit)
China Acute Migraine Drugs Market Segment Percentages, By Application, 2020 (%)
Hospital Pharmacies
Drug Stores
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Acute Migraine Drugs revenues in China market, 2016-2021 (Estimated), ($ millions)
Key companies Acute Migraine Drugs revenues share in China market, 2020 (%)
Key companies Acute Migraine Drugs sales in China market, 2016-2021 (Estimated), (K Unit)
Key companies Acute Migraine Drugs sales share in China market, 2020 (%)

Further, the report presents profiles of competitors in the market, key players include:

GSK
Teva
Pfizer
Novartis
Sun Pharma
Grunenthal
Endo Pharmaceuticals
Merck
J & J
1 Introduction to Research & Analysis Reports
1.1 Acute Migraine Drugs Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 China Acute Migraine Drugs Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 China Acute Migraine Drugs Overall Market Size
2.1 China Acute Migraine Drugs Market Size: 2021 VS 2027
2.2 China Acute Migraine Drugs Revenue, Prospects & Forecasts: 2016-2027
2.3 China Acute Migraine Drugs Sales: 2016-2027
3 Company Landscape
3.1 Top Acute Migraine Drugs Players in China Market
3.2 Top China Acute Migraine Drugs Companies Ranked by Revenue
3.3 China Acute Migraine Drugs Revenue by Companies
3.4 China Acute Migraine Drugs Sales by Companies
3.5 China Acute Migraine Drugs Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Acute Migraine Drugs Companies in China Market, by Revenue in 2020
3.7 Manufacturers Acute Migraine Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Acute Migraine Drugs Players in China Market
3.8.1 List of Tier 1 Acute Migraine Drugs Companies in China
3.8.2 List of Tier 2 and Tier 3 Acute Migraine Drugs Companies in China
4 Sights by Type
4.1 Overview
4.1.1 By Type - China Acute Migraine Drugs Market Size Markets, 2021 & 2027
4.1.2 Triptans
4.1.3 NSAIDs
4.1.4 Others
4.2 By Type - China Acute Migraine Drugs Revenue & Forecasts
4.2.1 By Type - China Acute Migraine Drugs Revenue, 2016-2021
4.2.2 By Type - China Acute Migraine Drugs Revenue, 2022-2027
4.2.3 By Type - China Acute Migraine Drugs Revenue Market Share, 2016-2027
4.3 By Type - China Acute Migraine Drugs Sales & Forecasts
4.3.1 By Type - China Acute Migraine Drugs Sales, 2016-2021
4.3.2 By Type - China Acute Migraine Drugs Sales, 2022-2027
4.3.3 By Type - China Acute Migraine Drugs Sales Market Share, 2016-2027
4.4 By Type - China Acute Migraine Drugs Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - China Acute Migraine Drugs Market Size, 2021 & 2027
5.1.2 Hospital Pharmacies
5.1.3 Drug Stores
5.2 By Application - China Acute Migraine Drugs Revenue & Forecasts
5.2.1 By Application - China Acute Migraine Drugs Revenue, 2016-2021
5.2.2 By Application - China Acute Migraine Drugs Revenue, 2022-2027
5.2.3 By Application - China Acute Migraine Drugs Revenue Market Share, 2016-2027
5.3 By Application - China Acute Migraine Drugs Sales & Forecasts
5.3.1 By Application - China Acute Migraine Drugs Sales, 2016-2021
5.3.2 By Application - China Acute Migraine Drugs Sales, 2022-2027
5.3.3 By Application - China Acute Migraine Drugs Sales Market Share, 2016-2027
5.4 By Application - China Acute Migraine Drugs Price (Manufacturers Selling Prices), 2016-2027
6 Manufacturers & Brands Profiles
6.1 GSK
6.1.1 GSK Corporation Information
6.1.2 GSK Overview
6.1.3 GSK Acute Migraine Drugs Sales and Revenue in China Market (2016-2021)
6.1.4 GSK Acute Migraine Drugs Product Description
6.1.5 GSK Recent Developments
6.2 Teva
6.2.1 Teva Corporation Information
6.2.2 Teva Overview
6.2.3 Teva Acute Migraine Drugs Sales and Revenue in China Market (2016-2021)
6.2.4 Teva Acute Migraine Drugs Product Description
6.2.5 Teva Recent Developments
6.3 Pfizer
6.3.1 Pfizer Corporation Information
6.3.2 Pfizer Overview
6.3.3 Pfizer Acute Migraine Drugs Sales and Revenue in China Market (2016-2021)
6.3.4 Pfizer Acute Migraine Drugs Product Description
6.3.5 Pfizer Recent Developments
6.4 Novartis
6.4.1 Novartis Corporation Information
6.4.2 Novartis Overview
6.4.3 Novartis Acute Migraine Drugs Sales and Revenue in China Market (2016-2021)
6.4.4 Novartis Acute Migraine Drugs Product Description
6.4.5 Novartis Recent Developments
6.5 Sun Pharma
6.5.1 Sun Pharma Corporation Information
6.5.2 Sun Pharma Overview
6.5.3 Sun Pharma Acute Migraine Drugs Sales and Revenue in China Market (2016-2021)
6.5.4 Sun Pharma Acute Migraine Drugs Product Description
6.5.5 Sun Pharma Recent Developments
6.6 Grunenthal
6.6.1 Grunenthal Corporation Information
6.6.2 Grunenthal Overview
6.6.3 Grunenthal Acute Migraine Drugs Sales and Revenue in China Market (2016-2021)
6.6.4 Grunenthal Acute Migraine Drugs Product Description
6.6.5 Grunenthal Recent Developments
6.7 Endo Pharmaceuticals
6.7.1 Endo Pharmaceuticals Corporation Information
6.7.2 Endo Pharmaceuticals Overview
6.7.3 Endo Pharmaceuticals Acute Migraine Drugs Sales and Revenue in China Market (2016-2021)
6.7.4 Endo Pharmaceuticals Acute Migraine Drugs Product Description
6.7.5 Endo Pharmaceuticals Recent Developments
6.8 Merck
6.8.1 Merck Corporation Information
6.8.2 Merck Overview
6.8.3 Merck Acute Migraine Drugs Sales and Revenue in China Market (2016-2021)
6.8.4 Merck Acute Migraine Drugs Product Description
6.8.5 Merck Recent Developments
6.9 J & J
6.9.1 J & J Corporation Information
6.9.2 J & J Overview
6.9.3 J & J Acute Migraine Drugs Sales and Revenue in China Market (2016-2021)
6.9.4 J & J Acute Migraine Drugs Product Description
6.9.5 J & J Recent Developments
7 China Acute Migraine Drugs Production Capacity, Analysis
7.1 China Acute Migraine Drugs Production Capacity, 2016-2027
7.2 Acute Migraine Drugs Production Capacity of Key Manufacturers in China Market
8 Key Market Trends, Opportunity, Drivers and Restraints
8.1 Market Opportunities & Trends
8.2 Market Drivers
8.3 Market Restraints
9 Acute Migraine Drugs Supply Chain Analysis
9.1 Acute Migraine Drugs Industry Value Chain
9.2 Acute Migraine Drugs Upstream Market
9.3 Acute Migraine Drugs Downstream and Clients
9.4 Marketing Channels Analysis
9.4.1 Marketing Channels
9.4.2 Acute Migraine Drugs Distributors and Sales Agents in China Market
10 Conclusion
11 Appendix
11.1 Note
11.2 Examples of Clients
11.3 Author Details
11.4 Disclaimer
List of Tables
    Table 1. Key Players of Acute Migraine Drugs in China Market
    Table 2. Top Acute Migraine Drugs Players in China Market, Ranking by Revenue (2019)
    Table 3. China Acute Migraine Drugs Revenue by Companies, (US$, Mn), 2016-2021
    Table 4. China Acute Migraine Drugs Revenue Share by Companies, 2016-2021
    Table 5. China Acute Migraine Drugs Sales by Companies, (K Unit), 2016-2021
    Table 6. China Acute Migraine Drugs Sales Share by Companies, 2016-2021
    Table 7. Key Manufacturers Acute Migraine Drugs Price (2016-2021) & (USD/Unit)
    Table 8. Manufacturers Acute Migraine Drugs Product Type
    Table 9. List of Tier 1 Acute Migraine Drugs Companies, Revenue (US$, Mn) in 2020 and Market Share
    Table 10. List of Tier 2 and Tier 3 Acute Migraine Drugs Companies, Revenue (US$, Mn) in 2020 and Market Share
    Table 11. Major Manufacturers of Triptans
    Table 12. Major Manufacturers of NSAIDs
    Table 13. By Type – China Acute Migraine Drugs Revenue, (US$, Mn), 2021 & 2027
    Table 14. By Type - China Acute Migraine Drugs Revenue (US$, Mn), 2016-2021
    Table 15. By Type - China Acute Migraine Drugs Revenue (US$, Mn), 2022-2027
    Table 16. By Type - China Acute Migraine Drugs Sales (K Unit), 2016-2021
    Table 17. By Type - China Acute Migraine Drugs Sales (K Unit), 2022-2027
    Table 18. By Application – China Acute Migraine Drugs Revenue, (US$, Mn), 2021 VS 2027
    Table 19. By Application - China Acute Migraine Drugs Revenue (US$, Mn), 2016-2021
    Table 20. By Application - China Acute Migraine Drugs Revenue (US$, Mn), 2022-2027
    Table 21. By Application - China Acute Migraine Drugs Sales (K Unit), 2016-2021
    Table 22. By Application - China Acute Migraine Drugs Sales (K Unit), 2022-2027
    Table 23. GSK Corporation Information
    Table 24. GSK Description and Major Businesses
    Table 25. GSK Acute Migraine Drugs Sales (K Unit), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
    Table 26. GSK Acute Migraine Drugs Product
    Table 27. GSK Recent Developments
    Table 28. Teva Corporation Information
    Table 29. Teva Description and Major Businesses
    Table 30. Teva Acute Migraine Drugs Sales (K Unit), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
    Table 31. Teva Acute Migraine Drugs Product
    Table 32. Teva Recent Developments
    Table 33. Pfizer Corporation Information
    Table 34. Pfizer Description and Major Businesses
    Table 35. Pfizer Acute Migraine Drugs Sales (K Unit), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
    Table 36. Pfizer Acute Migraine Drugs Product
    Table 37. Pfizer Recent Developments
    Table 38. Novartis Corporation Information
    Table 39. Novartis Description and Major Businesses
    Table 40. Novartis Acute Migraine Drugs Sales (K Unit), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
    Table 41. Novartis Acute Migraine Drugs Product
    Table 42. Novartis Recent Developments
    Table 43. Sun Pharma Corporation Information
    Table 44. Sun Pharma Description and Major Businesses
    Table 45. Sun Pharma Acute Migraine Drugs Sales (K Unit), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
    Table 46. Sun Pharma Acute Migraine Drugs Product
    Table 47. Sun Pharma Recent Developments
    Table 48. Grunenthal Corporation Information
    Table 49. Grunenthal Description and Major Businesses
    Table 50. Grunenthal Acute Migraine Drugs Sales (K Unit), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
    Table 51. Grunenthal Acute Migraine Drugs Product
    Table 52. Grunenthal Recent Developments
    Table 53. Endo Pharmaceuticals Corporation Information
    Table 54. Endo Pharmaceuticals Description and Major Businesses
    Table 55. Endo Pharmaceuticals Acute Migraine Drugs Sales (K Unit), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
    Table 56. Endo Pharmaceuticals Acute Migraine Drugs Product
    Table 57. Endo Pharmaceuticals Recent Developments
    Table 58. Merck Corporation Information
    Table 59. Merck Description and Major Businesses
    Table 60. Merck Acute Migraine Drugs Sales (K Unit), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
    Table 61. Merck Acute Migraine Drugs Product
    Table 62. Merck Recent Developments
    Table 63. J & J Corporation Information
    Table 64. J & J Description and Major Businesses
    Table 65. J & J Acute Migraine Drugs Sales (K Unit), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
    Table 66. J & J Acute Migraine Drugs Product
    Table 67. J & J Recent Developments
    Table 68. Acute Migraine Drugs Production Capacity (K Unit) of Key Manufacturers in China Market, 2019-2021 (K Unit)
    Table 69. China Acute Migraine Drugs Capacity Market Share of Key Manufacturers, 2019-2021
    Table 70. Acute Migraine Drugs Market Opportunities & Trends in China Market
    Table 71. Acute Migraine Drugs Market Drivers in China Market
    Table 72. Acute Migraine Drugs Market Restraints in China Market
    Table 73. Acute Migraine Drugs Raw Materials
    Table 74. Acute Migraine Drugs Raw Materials Suppliers in China Market
    Table 75. Typical Acute Migraine Drugs Downstream
    Table 76. Acute Migraine Drugs Downstream Clients in China Market
    Table 77. Acute Migraine Drugs Distributors and Sales Agents in China Market
List of Figures
    Figure 1. Acute Migraine Drugs Product Picture
    Figure 2. Acute Migraine Drugs Segment by Type
    Figure 3. Acute Migraine Drugs Segment by Application
    Figure 4. China Acute Migraine Drugs Market Overview: 2020
    Figure 5. China Acute Migraine Drugs Market Size: 2021 VS 2027 (US$, Mn)
    Figure 6. China Acute Migraine Drugs Revenue, 2016-2027 (US$, Mn)
    Figure 7. Acute Migraine Drugs Sales in China Market: 2016-2027 (K Unit)
    Figure 8. The Top 3 and 5 Players Market Share by Acute Migraine Drugs Revenue in 2020
    Figure 9. Triptans Product Picture
    Figure 10. NSAIDs Product Picture
    Figure 11. Others Product Picture
    Figure 12. By Type - China Acute Migraine Drugs Sales Market Share, 2016-2027
    Figure 13. By Type - China Acute Migraine Drugs Revenue Market Share, 2016-2027
    Figure 14. By Type - China Acute Migraine Drugs Price (USD/Unit), 2016-2027
    Figure 15. Hospital Pharmacies
    Figure 16. Drug Stores
    Figure 17. By Application - China Acute Migraine Drugs Sales Market Share, 2016-2027
    Figure 18. By Application - China Acute Migraine Drugs Revenue Market Share, 2016-2027
    Figure 19. By Application - China Acute Migraine Drugs Price (USD/Unit), 2016-2027
    Figure 20. GSK Acute Migraine Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 21. Teva Acute Migraine Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 22. Pfizer Acute Migraine Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 23. Novartis Acute Migraine Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 24. Sun Pharma Acute Migraine Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 25. Grunenthal Acute Migraine Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 26. Endo Pharmaceuticals Acute Migraine Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 27. Merck Acute Migraine Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 28. J & J Acute Migraine Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 29. China Acute Migraine Drugs Production Capacity (K Unit), 2016-2027
    Figure 30. Acute Migraine Drugs Industry Value Chain
    Figure 31. Marketing Channels
SELECT A FORMAT
Added to Cart

Electronic (PDF)
$3400
This license allows only one user(purchaser of the report) to access the PDF.

Electronic (PDF)
$5100
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Electronic (PDF)
$6800
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
SecuX Technology Inc

RELATED REPORTS

China Antipyretic Analgesics Market Report Forecast 2021 2027
China Antipyretic Analgesics Market Report & Forecast 2021-2027

120 Pages
Type: Report
Code: QYRE-Auto-20T5723
Sat Oct 02 00:00:00 UTC 2021

Add to Cart

Global and United States Knee Pain Management Market Size Status and Forecast 2021 2027
Global and United States Knee Pain Management Market Size, Status and Forecast 2021-2027

120 Pages
Type: Report
Code: QYRE-Auto-30J6482
Sun Sep 05 00:00:00 UTC 2021

Add to Cart

Global Ketoprofen Market Size Manufacturers Supply Chain Sales Channel and Clients 2021 2027
Global Ketoprofen Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2021-2027

Top 3 companies occupied about 83 market share.Market Analysis and Insights Global Ketoprofen MarketIn 2020 the global Ketoprofen market size was US 34 million and it is expected to reach US 39 million by the end of 2027 with a CAGR of 1.9 during 20212027.Global Ketoprofen Scope and Market SizeKetoprofen market is segmented by region by country company t.

120 Pages
Type: Report
Code: QYRE-Auto-2K2665
Fri Aug 13 00:00:00 UTC 2021

Add to Cart

Global and United States Pain Management Therapeutics Market Size Status and Forecast 2021 2027
Global and United States Pain Management Therapeutics Market Size, Status and Forecast 2021-2027

120 Pages
Type: Report
Code: QYRE-Auto-26P6025
Thu Aug 12 00:00:00 UTC 2021

Add to Cart